Vivos (RDGL) Assets Growth (3y) (2013 - 2025)
Powered by 
Analysis
Vivos (RDGL) Assets Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | 35.81% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | -15.24% |
| Jun 30, 2024 | -7.46% |
| Mar 31, 2024 | -18.13% |
| Dec 31, 2023 | 19.75% |
| Sep 30, 2023 | 200.20% |
| Jun 30, 2023 | 81.45% |
| Dec 31, 2022 | 241.20% |
| Sep 30, 2022 | 118.16% |
| Jun 30, 2022 | 184.17% |
| Mar 31, 2022 | 183.63% |
| Dec 31, 2021 | 362.81% |
| Sep 30, 2021 | 458.51% |
| Jun 30, 2021 | 549.18% |
| Mar 31, 2021 | 1,443.53% |
| Dec 31, 2020 | 290.89% |